Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Guangzhou Sport University | OTHER |
Not provided
Not provided
Not provided
Not provided
A 12-week randomized controlled trail was conducted in 72 Chinese breast cancer survivors who had received aromatase inhibitors treatment for more than 6 months. All participants were assigned to either 12 weeks of Baduanjin classes which involved to two 90-minute sessions per week or a wait-list control. Participants completed fitness assessments, measurements of lipopolysaccharide-stimulated production of proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), interleukin-1β(IL-1β) ,C-reactive protein (CRP) ，BMI，BMD and questionnaires to measure QoL, fatigue, sleep quality, Aromatase Inhibitor-Induced Arthralgia, symptoms of climacteric syndrome were completed at baseline and 3 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise group | Experimental | After completing the baseline tests, participants in exercise group were instructed to attend 90-minute, supervised Baduanjin exercise 2 times per week. The Baduanjin intervention used the standardized Baduanjin training program, designed by the General Administration of Sports of China. Two senior Baduanjin teachers from Guangzhou Sports University conducted the training. |
|
| Waiting list Control group | Experimental | Participants assigned to the wait-list control were told to continue performing their usual care and daily activities, and to refrain from doing any Baduanjin exercise. After their post-assessment they were able to attend the Baduanjin classes. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Baduanjin exercise | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline Quality of Life (QoL) at 3 months | European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 version 3 (EORTC QLQ-C30) | at baseline and 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline IL-6 at 3 months | proinflammatory cytokines interleukin-6 | at baseline and 3 months |
| Change from Baseline Fatigue at 3 months | Piper fatigue questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kun Wang | Guangdong Provincial People's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Guangdong General Hospital | Guangzhou | Guangdong | 510080 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| at baseline and 3 months |
| Change from Baseline sleep quality at 3 months | Pittsburgh sleep quality index, PSQI | at baseline and 3 months |
| Change from Baseline Aromatase Inhibitor-Induced Arthralgia at 3 months | Brief Pain Inventory-Short Form | at baseline and 3 months |
| Change from Baseline Symptoms of climacteric syndrome at 3 months | Kupperman Index | at baseline and 3 months |
| Change from Baseline BMD at 3 months | Bone mineral density | at baseline and 3 months |
| Change from Baseline BMI at 3 months | Body Mass Index | at baseline and 3 months |
| Change from Baseline Aerobic Fitness Assessment at 3 months | Six-min walk test (6MWT) | at baseline and 3 months |
| Change from Baseline Muscle strength test at 3 months | Upper strength: hand grip (measured by a dynamometer; the average of 3 readings) lower limb strength：sit-to-stand (measured as number of reps in a 30-s period) | at baseline and 3 months |
| Change from Baseline Flexibility test at 3 months | Test of scratching his back and Sit in the chair and reach | at baseline and 3 months |
| Change from Baseline Balance test at 3 months | stand on one foot | at baseline and 3 months |
| Change from Baseline TNF-α at 3 months | tumor necrosis factor alpha | at baseline and 3 months |
| Change from Baseline IL-1β at 3 months | interleukin-1β | at baseline and 3 months |
| Change from Baseline CRP at 3 months | C-reactive protein | at baseline and 3 months |
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided